Acute Lymphoblastic Leukemia: Optimizing MRD Testing
0 Visninger
• 06/15/23
0
0
Indlejre
administrator
Abonnenter
Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; and Bijal D. Shah, MD, reflect on the optimal time to test for minimal residual disease and how to best interpret the results regarding the prognosis of a patient with acute lymphoblastic leukemia.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer